Taken together, reduced colony formation of AML ADAM10 KO PDX cells and reduced LSC frequencies in ALL PDX models in vivo suggest that targeting ADAM10 may represent a suitable approach to reduce LSC numbers. Here, ADAM10 is linked to acute myeloid leukemia.